Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer
Veronesi U et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227-1232
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
Fisher B et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 341: 1233-1241
Effects of radiotherapy and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials
Clarke M et al. (2005) Effects of radiotherapy and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials. Lancet 366: 2087-2106
Accelerated partial breast irradiation: An updated report from the American Brachytherapy Society
Corrected and republished in: (2003) Brachytherapy 2: 124-130
Arthur DW et al. (2002) Accelerated partial breast irradiation: An updated report from the American Brachytherapy Society. Brachytherapy 1: 184-190 Corrected and republished in: (2003) Brachytherapy 2: 124-130
Consensus statement for accelerated partial breast irradiation
The American Society of Breast Surgeons (online 8 December 2005) (accessed 18 December)
The American Society of Breast Surgeons (online 8 December 2005) Consensus statement for accelerated partial breast irradiation. [http://www.breastsurgeons.org/apbi.shtml] (accessed 18 December 2006)
(2006)
8
0042641528
Limited-field radiation therapy in the management of early stage breast cancer
Vicini F et al. (2003) Limited-field radiation therapy in the management of early stage breast cancer. JNCI 95: 1205-1210
The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy
Baglan K et al. (2001) The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 50: 1003-1011
Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer
King TA et al. (2000) Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180: 299-304
HDR brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving sugery: Seven-year results of a comparative study
Polgar C et al. (2004) HDR brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving sugery: Seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60: 1173-1181
Interstitial brachytherapy alone after breast conserving surgery: Interim results of 2 german-austrian multi-center phase II trial
Strand V et al. (2004) Interstitial brachytherapy alone after breast conserving surgery: Interim results of 2 german-austrian multi-center phase II trial. Brachytherapy 3: 115-119
PDR brachytherapy as the sole adjuvant radiotherapy after breast conserving surgery of T1-2 breast cancer
[abstract PP87]. In 2000 November 11-14 Madrid, Spain. Nucletron, 2000
Johansson B et al. (2000) PDR brachytherapy as the sole adjuvant radiotherapy after breast conserving surgery of T1-2 breast cancer [abstract PP87]. In Program & abstracts 10th International Brachytherapy Conference: 2000 November 11-14 Madrid, Spain. Nucletron, 2000:127
Treatment volume and dose optimization of the MammoSite breast brachytherapy applicator
Dickler A et al. (2004) Treatment volume and dose optimization of the MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 59: 469-474
Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator
Edmundson G et al. (2002) Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 52: 1132-1139
Clinical evaluations of the MammoSite breast brachytherapy catheter: An analysis of technical reproducibility, acute toxicity, and patient demographics
[abstract]
Gittleman M et al. (2003) Clinical evaluations of the MammoSite breast brachytherapy catheter: An analysis of technical reproducibility, acute toxicity, and patient demographics [abstract]. Int J Radiat Oncol Biol Phys 57 (Suppl): S365-S366
Two-year outcome with the MammoSite breast brachytherapy applicator: Factors associated with optimal cosmetic outcome when performing partial breast irradiation
Keisch M et al. (2003) Two-year outcome with the MammoSite breast brachytherapy applicator: Factors associated with optimal cosmetic outcome when performing partial breast irradiation. Int J Radiat Oncol Biol Phys 57: S311
Postlumpectomy Insertion of the MammoSite device using the scar entry technique: Initial experience and technical considerations
Stolier A et al. (2005) Postlumpectomy Insertion of the MammoSite device using the scar entry technique: Initial experience and technical considerations. Breast J 11: 199-203
First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: Results of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial
Vicini F et al. (2005) First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: Results of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. Cancer 104: 1338-1348
Forty-eight month results with the MammoSite brachytherapy applicator: Details regarding cosmesis, toxicity and local control in partial breast irradiation
[abstract #157661]. 2005 October 16-20; Denver, CO
Keisch M et al. (2005) Forty-eight month results with the MammoSite brachytherapy applicator: Details regarding cosmesis, toxicity and local control in partial breast irradiation [abstract #157661]. Proceedings of the ASTRO Annual Meeting: 2005 October 16-20; Denver, CO
Acute complications of MammoSite brachytherapy: A single institution's initial clinical experience
Harper JL et al. (2005) Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 61: 169-174
Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer
Richards GM et al. (2004) Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 11: 739-746
Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: Initial clinical experience
DiFronzo LA et al. (2005) Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: Initial clinical experience. Arch Surg 140: 787-794
Clinical experience with the MammoSite radiation system for brachytherapy of breast cancer: Results from an international phase II trial
Niehoff P et al. (2006) Clinical experience with the MammoSite radiation system for brachytherapy of breast cancer: Results from an international phase II trial. Radiother Oncol 79: 316-320
A dosimetric comparison of three-dimensional conformal, intensity-modulated radiation therapy, and MammoSite partial-breast irradiation
Khan AJ et al. (2006) A dosimetric comparison of three-dimensional conformal, intensity-modulated radiation therapy, and MammoSite partial-breast irradiation. Brachytherapy 5: 183-188
Conservative surgery for the management of invasive and non-invasive carcinoma of the breast: NSABP trials
Fisher B and Anderson S (1994) Conservative surgery for the management of invasive and non-invasive carcinoma of the breast: NSABP trials. W J Surg 18: 63-69
A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: Initial outcomes of RTOG 9517
[abstract #565]. 2004 October 3-7; Atlanta, GA
Kuske R et al. (2004) A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: Initial outcomes of RTOG 9517 [abstract #565]. Proceedings of the ASCO Annual Meeting: 2004 October 3-7; Atlanta, GA